MIT’s Next-Gen AI Screens Millions of Molecules at Supercomputer Speed for Drug Study The race to accelerate drug discovery has found a powerful ally. Boltz-2, a next-generation biomolecular artificial intelligence system developed by researchers at the Massachusetts Institute of Technology (MIT), is revolutionizing the field of pharmaceutical research. With the ability to screen millions of […]
Category: Pharmaceutical Research
Back To Top